Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Efficacy and Toxicity of Donor Lymphocyte Infusions in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience

Ioanna Sakellari, Varnavas Konstantinou, Eleni Gavriilaki, MD PhD, Despina Mallouri, Ioannis Batsis, MD, Vassiliki Kalaitzidou, Chrysa Apostolou, Maria Kaliou, Anastasia Bouinta, Christos Smias, MD, Panayotis Kaloyannidis, MD, Damianos Sotiropoulos, MD, Evangelia Yannaki, MD, Achilles Anagnostopoulos

Blood (2016) 128 (22): 5804.

https://doi.org/10.1182/blood.V128.22.5804.5804

Published: 2016

Journal Articles

Transplant-Associated Thrombotic Microangiopathy: Prevalence, Prognostic Factors and Treatment Outcomes in Unrelated Allogeneic Transplant for Hematologic Diseases

Ioanna Sakellari, Ioannis Batsis, MD, Zoi Boussiouu, Despina Mallouri, Varnavas Konstantinou, Michail Iskas, MD, Anna Vardi, Stergios Papadimitriou, MDResident, Alkistis Panteliadou, Christos Smias, MD, Evangelia Yannaki, MD, Asimina Fylaktou, Aliki Tsompanakou, Chrysanthi Vadikoliou, Panayotis Kaloyannidis, MD, Taisir Natse, Gerasimos Bamichas, Eleni Gavriilaki, MD PhD, Achilles Anagnostopoulos

Blood (2016) 128 (22): 982.

https://doi.org/10.1182/blood.V128.22.982.982

Published: 2016

Journal Articles

An Optimized, Large Scale Generation and Validation of Aspergillus-Specific T Lymphocytes for the Management of Invasive Aspergillosis in Immunocompromised Patients

Anastasia Papadopoulou, PhD, Panayotis Kaloyannidis, MD, Maria Alvanou, Joanne Kalogeropoulou, Achilles Anagnostopoulos, Evangelia Yannaki, MD

Blood (2015) 126 (23): 4293.

https://doi.org/10.1182/blood.V126.23.4293.4293

Published: 2015

Journal Articles

Survival Advantage with Comparable Complete Chimerism Patterns in Reduced Toxicity Treosulfan-Based Vs Reduced Intensity Busulfan-Based Conditinioning Regimen in AML/MDS Patients Undergoing Allogeneic Haematopoietic Cell Transplantation

Ioannis Batsis, MD, Ioanna Sakellari, MD PhD, Apostolia Papalexandri, Despina Mallouri, Sofia Charalampidou, Maria Kaliou, Achilleas Afisidis, Eleni Gavriilaki, MD, Varnavas C Constantinou, MD, Evangelia Yannaki, MD, Panayotis Kaloyannidis, MD, Chrysa Apostolou, Damianos Sotiropoulos, MD, Chrysanthi Vadikolia, MD, Christos Smias, MD, Achilles Anagnostopoulos

Blood (2015) 126 (23): 1914.

https://doi.org/10.1182/blood.V126.23.1914.1914

Published: 2015

Journal Articles

An Optimized, Ex Vivo Log-Scale Expansion of UCB-Derived Myeloid Dcs, Towards Efficient Cancer Immunotherapy

Eleni Gounari, Anastasia Papadopoulou, PhD, Minas Yiangou, Prof, Angeliki E Xagorari, PhD, Achilles Anagnostopoulos, MD, Evangelia Yannaki, MD, Panayotis Kaloyannidis, MD

Blood (2014) 124 (21): 2441.

https://doi.org/10.1182/blood.V124.21.2441.2441

Published: 2014

Journal Articles

Efficacy and Toxicity of Conditioning Regimens BEAM and BEM in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results of a Comparative (Matched Pair) Analysis

Ioanna Sakellari, Despina Mallouri, MD, Batsis Ioannis, Constantinou Varnavas, Iskas Michalis, Baliakas Panayotis, Karypidis Kyriakos, Georgiadou Elissavet, Douka Vassiliki, Ampela Elma, Anastasia Marvaki, Apostolou Chrysoula, Damianos Sotiropoulos, Evangelia Yannaki, md, Panayotis Kaloyannidis, MD, Achilles Anagnostopoulos

Blood (2012) 120 (21): 4530.

https://doi.org/10.1182/blood.V120.21.4530.4530

Published: 2012

Journal Articles

Impaired Antibody RESPONSE FOLLOWING VACCINATION Against Hepatitis-B VIRUS In Autografted PATIENTS for Hematologic Malignancies: PRELIMINARY RESULTS

Panayotis Kaloyannidis, MD, Varnavas Konstantinou, MD, Elisavet Georgiadou, MD, Fani Zervou, Ioannis Batsis, MD, Despina Mallouri, MD, Evangelia Yannaki, MD, Maria Papathanasiou, MD, Aliki Xoheli, MD, Ioanna Sakellari, George Kiriazis, MD, Achilles Anagnostopoulos, MD

Blood (2011) 118 (21): 1999.

https://doi.org/10.1182/blood.V118.21.1999.1999

Published: 2011

Journal Articles

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Evangelia Yannaki, MD, Thalia Papayannopoulou, Erica Jonlin, PhD, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, PhD, Pamela S. Becker, MD, PhD, Nikoleta Psatha, Ioannis Batsis, MD, Panayotis Kaloyannidis, MD, Varvara Tahynopoulou, Varnavas Constantinou, Asimenia Bouinta, Konstantia Kotta, Aglaia Athanassiadou, PhD, Achilles Anagnostopoulos, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2011) 118 (21): 166.

https://doi.org/10.1182/blood.V118.21.166.166

Published: 2011

Journal Articles

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Evangelia Yannaki, MD, Thalia Papayannopoulou, MD, Erica Jonlin, PhD, Ioannis Batsis, MD, Pamela S. Becker, MD, PhD, Fani Zervou, BS, Angeliki Xagorari, PhD, Garyfalia Karponi, BS, Varvara Tahynopoulou, BS, Panayotis Kaloyannidis, MD, Varnavas Constantinou, MD, Achilles Anagnostopoulos, MD, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2009) 114 (22): 2150.

https://doi.org/10.1182/blood.V114.22.2150.2150

Published: 2009

Journal Articles

Desferrioxamine Administration Post Allogeneic Stem Cell Transplantation Reduces the Relapse Risk and Improves the Disease Free Survival.

Panayotis Kaloyannidis, MD, Evangelia Yannaki, MD, Aikaterini Mpitzioni, MD, Ioannis Batsis, MD, Despina Mallouri, MD, Dimitrios Bartzoudis, MD, Ioanna Sakellari, MD, Achilles Anagnostopoulos, MD

Blood (2008) 112 (11): 3254.

https://doi.org/10.1182/blood.V112.11.3254.3254

Published: 2008

Journal Articles

Rheumatoid Arthritis as a New Disease-Target for Bortezomib.

Evangelia Yannaki, MD, Anastasia Papadopoulou, PhD student, Argyrw Paraskeva, BS, Panayotis Kaloyannidis, MD, Evangelia Athanasiou, MD, Dimitris Bougiouklis, BS, Panayotis Palladas, MD, Minas Yiangou, PhD, Athanasios Fassas, MD, Achilles Anagnostopoulos

Blood (2008) 112 (11): 1543.

https://doi.org/10.1182/blood.V112.11.1543.1543

Published: 2008

Journal Articles

Immunized Against Hepatitis B Virus Allografted Recipients Are at High Risk for Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer: A Study of 82 Allografted Long Term Survivors.

Panayotis Kaloyannidis, MD, Evangelia Yannaki, MD, Ioannis Batsis, MD, Despoina Adamidou, MD, Demetrios Bartzoudis, MD, Maria Papathanasiou, MD, Despoina Mallouri, MD, Ioanna Sakellari, MD, Athanasios Fassas, MD, Achilles Anagnostopoulos, MD

Blood (2006) 108 (11): 2862.

https://doi.org/10.1182/blood.V108.11.2862.2862

Published: 2006

NARROW

Efficacy and Toxicity of Donor Lymphocyte Infusions in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience

Transplant-Associated Thrombotic Microangiopathy: Prevalence, Prognostic Factors and Treatment Outcomes in Unrelated Allogeneic Transplant for Hematologic Diseases

An Optimized, Large Scale Generation and Validation of Aspergillus-Specific T Lymphocytes for the Management of Invasive Aspergillosis in Immunocompromised Patients

Survival Advantage with Comparable Complete Chimerism Patterns in Reduced Toxicity Treosulfan-Based Vs Reduced Intensity Busulfan-Based Conditinioning Regimen in AML/MDS Patients Undergoing Allogeneic Haematopoietic Cell Transplantation

An Optimized, Ex Vivo Log-Scale Expansion of UCB-Derived Myeloid Dcs, Towards Efficient Cancer Immunotherapy

Efficacy and Toxicity of Conditioning Regimens BEAM and BEM in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results of a Comparative (Matched Pair) Analysis

Impaired Antibody RESPONSE FOLLOWING VACCINATION Against Hepatitis-B VIRUS In Autografted PATIENTS for Hematologic Malignancies: PRELIMINARY RESULTS

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Desferrioxamine Administration Post Allogeneic Stem Cell Transplantation Reduces the Relapse Risk and Improves the Disease Free Survival.

Rheumatoid Arthritis as a New Disease-Target for Bortezomib.

Immunized Against Hepatitis B Virus Allografted Recipients Are at High Risk for Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer: A Study of 82 Allografted Long Term Survivors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only